Zentek (ZEN) Stock Price, News & Analysis

Company Overview

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Key Stats

• Today's Range: C$0.53 to C$0.56
• 50-Day Range: C$0.55 to C$0.85
• 52-Week Range: C$0.52 to C$1.50
• Volume: 110,918 shs
• Average Volume: 137,570 shs
• Market Capitalization: C$69.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

Zentek Stock Analysis - MarketRank™

Zentek scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.2 / 5
• Analyst Rating: Strong Buy

Amount of Analyst Coverage

Zentek has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Zentek is -5.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Zentek is -5.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Zentek has a P/B Ratio of 2.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for ZEN.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Zentek does not currently pay a dividend.

Dividend Growth

Zentek does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: N/A

News Sentiment

Zentek has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Zentek this week, compared to 0 articles on an average week.

Search Interest

2 people have searched for ZEN on MarketBeat in the last 30 days.

Company Ownership

• Score: 3.1 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net C$8,200.00 in company stock, which represents 0.0118% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Zentek insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$8,200.00 in company stock and sold C$0.00 in company stock.

Percentage Held by Insiders

6.01% of the stock of Zentek is held by insiders.

Percentage Held by Institutions

0.05% of the stock of Zentek is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: CVE:ZEN
• CIK: N/A
• Web: www.zentek.com
• Phone: +1-807-3461660
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$10.75 million
• Net Margins: -9,652.83%
• Pretax Margin: N/A
• Return on Equity: -70.73%
• Return on Assets: -27.09%

Debt

• Debt-to-Equity Ratio: 7.62
• Current Ratio: 4.65
• Quick Ratio: 7.59

Sales & Book Value

• Annual Sales: C$108.25 thousand
• Price / Sales: 643.33
• Cash Flow: C$0.04 per share
• Price / Cash Flow: 13.85
• Book Value: C$0.22 per share
• Price / Book: 2.51

Miscellaneous

• Outstanding Shares: 126,620,000
• Free Float: N/A
• Market Cap: C$69.64 million
• Optionable: Not Optionable
• Beta: 0.25